Both can be paired with Ipamorelin using the same dual-pathway rationale
Han X, Yuan T, Zhang J, Shi Y, Li D, Dong Y, Fan S
Whilst the research into GLP-1 receptor agonists and Parkinson's disease is promising, it remains in relatively early stages, and robust evidence from large-scale trials is needed before these drugs can be recommended for neuroprotection or symptom management in Parkinson's disease
Introduction Finding the right way to support your cellular health can often feel like piecing together a complex puzzle
A comprehensive panel of antibodies was utilized for Western blotting, targeting phosphorylated and total forms of ERK1/2, p38 MAPK, JNK1/2, and NF-B p65 (Ser536), with -actin serving as a loading control